MIR548AL

Across TCGA pan-cancer cohorts, MIR548AL RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR548AL data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MIR548AL RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548AL expression acts as an unfavorable survival marker.

KICH, CHOL, and KIRC are the cancer types where MIR548AL RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
CHOL	OS	Tertile	All	0.019	0.800	<.001	72	view →
KIRC	DFS	Tertile	IV	0.039	0.632	<.001	36	view →
BRCA	DFS	Tertile	All	0.857	0.951	.009	24	view →
LGG	OS	Tertile	All	0.585	0.810	.007	24	view →
TGCT	OS	Tertile	All	0.694	0.968	.002	18	view →
KIRP	DFS	Tertile	II,III,IV	0.157	0.686	.031	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MIR548AL–KICH (DFS)

Open the KICH breakdown →